Kontrastverstärkte Sonografie und Endosonografie zur Diagnostik von
                    Pankreaserkrankungen

M. Hocke; C. Dietrich

doi:10.1055/s-0033-1350630

Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie, Table of Contents

Zentralbl Chir 2014; 139(3): 301-307
DOI: 10.1055/s-0033-1350630

Übersicht

Georg Thieme Verlag KG Stuttgart · New York

Kontrastverstärkte Sonografie und Endosonografie zur Diagnostik von Pankreaserkrankungen

Contrast-Enhanced Sonography and Endoscopic Ultrasound for the Diagnosis of Pancreatic Diseases

M. Hocke

¹Medizinische Klinik II, Klinikum Meiningen GmbH, Meiningen, Deutschland

,

C. Dietrich

²Klinik für Innere Medizin 2, Caritas-Krankenhaus, Bad Mergentheim, Deutschland

› Author Affiliations

Abstract

Zusammenfassung

Kontrastverstärkte Ultraschallmethoden haben die diagnostischen Möglichkeiten des klinischen Ultraschalls in den letzten Jahren erheblich erweitert. Kontrastmittelspezifische Software in Verbindung mit Ultraschallkontrastmitteln der 2. Generation haben dabei den Ultraschallmethoden eine Aussagekraft gegeben, die manchmal weit über die Möglichkeiten der anderen schnittbildgebenden Verfahren hinausreicht. Der folgende Artikel befasst sich mit den Anwendungsmöglichkeiten des kontrastverstärkten Ultraschalls zur Diagnostik von Pankreaserkrankungen inklusive des endoskopischen Ultraschalls. Der Leser soll mit dem Artikel in die Lage versetzt werden, die Schwächen und Stärken des kontrastverstärkten Ultraschalls kennenzulernen, um die Methode sinnvoll zur Diagnostik von Pankreaserkrankungen einzusetzen.

Abstract

Contrast-enhanced ultrasound (CEUS) has increased the diagnostic spectrum of clinical ultrasound. Especially the introduction of specific contrast-enhanced software in connection with the development of second generation contrast enhancers has enabled the development of CEUS to a stage where it sometimes furnishes better diagnostic results than any other cross-sectional diagnostic imaging method. The present article should provide the reader with an overview about the diagnostic possibilities of CEUS including contrast-enhanced endoscopic ultrasound. The reader should then be able to understand the weaknesses and strengths of CEUS in the diagnostic apporach to pancreatic diseases.

Schlüsselwörter

bildgebende Verfahren - Endosonografie - Kontrastmittelsonografie

Key words

imaging procedures - endoscopic ultrasonography (EUS) - contrast medium-guided ultrasound

Full Text

References

Literatur
1 Bennett WF, Bova JG. Review of hepatic imaging and a problem-oriented approach to liver masses. Hepatology 1990; 12: 761-775
2 Dietrich CF, Ignee A, Trojan J et al. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004; 53: 401-405
3 Solbiati L, Tonolini M, Cova L et al. The role of contrast-enhanced ultrasound in the detection of focal liver leasions. Eur Radiol 2001; 11 (Suppl. 03) E15-E26
4 Claudon M, Cosgrove D, Albrecht T et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008. Ultraschall Med 2008; 29: 28-44
5 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver – update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39: 187-210
6 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 2013; 34: 11-29
7 Dietrich CF, Jenssen C. [Focal liver lesion, incidental finding]. Dtsch Med Wochenschr 2012; 137: 2099-2116
8 Dietrich CF, Maddalena ME, Cui XW et al. Liver tumor characterization–review of the literature. Ultraschall Med 2012; 33 (Suppl. 01) S3-S10
9 Dietrich CF. Liver tumor characterization–comments and illustrations regarding guidelines. Ultraschall Med 2012; 33 (Suppl. 01) S22-S30
10 Barreiros AP, Piscaglia F, Dietrich CF. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. J Hepatol 2012; 57: 930-932
11 Dietrich CF, Ignee A, Hocke M et al. Pitfalls and artefacts using contrast enhanced ultrasound. Z Gastroenterol 2011; 49: 350-356
12 Pirri C, Cui XW, De Molo C et al. The pancreatic head is larger than often assumed. Z Gastroenterol 2013; 51: 390-394
13 Sienz M, Ignee A, Dietrich CF. [Reference values in abdominal ultrasound – biliopancreatic system and spleen]. Z Gastroenterol 2011; 49: 845-870
14 Piscaglia F, Nolsoe C, Dietrich CF et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 2012; 33: 33-59
15 Dietrich CF, Cui XW, Schreiber-Dietrich DG et al. EFSUMB guidelines 2011: comments and illustrations. Ultraschall Med 2012; 33 (Suppl. 01) S11-S21
16 Keck T. [Carcinoma of the pancreas: current status of multimodal therapy]. Zentralbl Chir 2011; 136: 352-358
17 Herzog J, Eickhoff A. [Endoscopic therapy for tumours of the papilla of vater]. Zentralbl Chir 2012; 137: 527-534
18 Herzog T, Belyaev O, Uhl W et al. [Hepaticojejunostomy after pancreatic head resection – technical aspects for reconstruction of small and fragile bile ducts with T-tube drainage]. Zentralbl Chir 2012; 137: 559-564
19 Saftoiu A, Dietrich CF, Vilmann P. Contrast-enhanced harmonic endoscopic ultrasound. Endoscopy 2012; 44: 612-617
20 Nuernberg D, Ignee A, Dietrich CF. [Ultrasound in gastroenterology. Biliopancreatic system]. MedKlin (Munich) 2007; 102: 112-126
21 Hancke S. Ultrasonic scanning of the pancreas. J Clin Ultrasound 1976; 4: 223-230
22 Rickes S, Uhle C, Kahl S et al. Echo enhanced ultrasound: a new valid initial imaging approach for severe acute pancreatitis. Gut 2006; 55: 74-78
23 Golea A, Badea R, Socaciu M et al. Quantitative analysis of tissue perfusion using contrast-enhanced transabdominal ultrasound (CEUS) in the evaluation of the severity of acute pancreatitis. Med Ultrason 2010; 12: 198-204
24 Ripolles T, Martinez MJ, Lopez E et al. Contrast-enhanced ultrasound in the staging of acute pancreatitis. Eur Radiol 2010; 20: 2518-2523
25 Delis SG, Dervenis C. Current trends in the prevention and treatment of infection in the setting of acute pancreatitis. Infect Disord Drug Targets 2010; 10: 1
26 Dietrich CF, Hirche TO, Ott M et al. Real-time tissue elastography in the diagnosis of autoimmune pancreatitis. Endoscopy 2009; 41: 718-720
27 Dietrich CF, Jenssen C, Allescher HD et al. [Differential diagnosis of pancreatic lesions using endoscopic ultrasound]. Z Gastroenterol 2008; 46: 601-617
28 Shinagare S, Shinagare AB, Deshpande V. Autoimmune pancreatitis: a guide for the histopathologist. Semin Diagn Pathol 2012; 29: 197-204
29 Tabata T, Kamisawa T, Takuma K et al. Differences between diffuse and focal autoimmune pancreatitis. World J Gastroenterol 2012; 18: 2099-2104
30 Milosavljevic T, Kostic-Milosavljevic M, Jovanovic I et al. Extraintestinal manifestations of autoimmune pancreatitis. Dig Dis 2012; 30: 220-223
31 Stone JH. IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 2012; 29: 177-190
32 Hocke M, Ignee A, Dietrich CF. Three-dimensional contrast-enhanced endoscopic ultrasound for the diagnosis of autoimmune pancreatitis. Endoscopy 2011; 43 (Suppl. 2) UCTN: E381-E382
33 Hocke M, Ignee A, Dietrich CF. Contrast-enhanced endoscopic ultrasound in the diagnosis of autoimmune pancreatitis. Endoscopy 2011; 43: 163-165
34 Numata K, Ozawa Y, Kobayashi N et al. Contrast-enhanced sonography of autoimmune pancreatitis: comparison with pathologic findings. J Ultrasound Med 2004; 23: 199-206
35 Jenssen C, Dietrich CF. Endoscopic ultrasound in chronic pancreatitis. Z Gastroenterol 2005; 43: 737-749
36 Choueiri NE, Balci NC, Alkaade S et al. Advanced imaging of chronic pancreatitis. Curr Gastroenterol Rep 2010; 12: 114-120
37 Dietrich CF, Hocke M. Endosonographie zystischer Pankreasläsionen. Viszeralmedizin 2011; 27: 194-204
38 Beyer-Enke SA, Hocke M, Ignee A et al. Contrast enhanced transabdominal ultrasound in the characterisation of pancreatic lesions with cystic appearance. JOP 2010; 11: 427-433
39 DʼOnofrio M, Barbi E, Dietrich CF et al. Pancreatic multicenter ultrasound study (PAMUS). Eur J Radiol 2012; 81: 630-638
40 Rickes S, Wermke W. Differentiation of cystic pancreatic neoplasms and pseudocysts by conventional and echo-enhanced ultrasound. J Gastroenterol Hepatol 2004; 19: 761-766
41 Dietrich CF, Jenssen C. [Evidence based endoscopic ultrasound]. Z Gastroenterol 2011; 49: 599-621
42 Vasile TA, Socaciu M, Stan IR et al. Added value of intravenous contrast-enhanced ultrasound for characterization of cystic pancreatic masses: a prospective study on 37 patients. Med Ultrason 2012; 14: 108-114
43 Hirooka Y, Goto H, Ito A et al. Contrast-enhanced endoscopic ultrasonography in pancreatic diseases: a preliminary study. Am J Gastroenterol 1998; 93: 632-635
44 Dietrich CF, Ignee A, Braden B et al. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol 2008; 6: 590-597
45 Dietrich CF, Ignee A, Frey H. Contrast-enhanced endoscopic ultrasound with low mechanical index: a new technique. Z Gastroenterol 2005; 43: 1219-1223
46 Dietrich CF. Contrast-enhanced low mechanical index endoscopic ultrasound (CELMI-EUS). Endoscopy 2009; 41 (Suppl. 02) E43-E44
47 Hocke M, Ignee A, Dietrich CF. Advanced endosonographic diagnostic tools for discrimination of focal chronic pancreatitis and pancreatic carcinoma–elastography, contrast enhanced high mechanical index (CEHMI) and low mechanical index (CELMI) endosonography in direct comparison. Z Gastroenterol 2012; 50: 199-203
48 Turner BG, Brugge WR. Pancreatic cystic lesions: when to watch, when to operate, and when to ignore. Curr Gastroenterol Rep 2010; 12: 98-105
49 Brugge WR, Lewandrowski K, Lee-Lewandrowski E et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004; 126: 1330-1336
50 Yoon WJ, Brugge WR. Pancreatic cystic neoplasms: diagnosis and management. Gastroenterol Clin North Am 2012; 41: 103-118
51 Hawes RH, Clancy J, Hasan MK. Endoscopic ultrasound-guided fine needle aspiration in cystic pancreatic lesions. Clin Endosc 2012; 45: 128-131
52 Kocjan G. Fine needle aspiration cytology of the pancreas: a guide to the diagnostic approach. Coll Antropol 2010; 34: 749-756
53 Cizginer S, Turner B, Bilge AR et al. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas 2011; 40: 1024-1028
54 Jenssen C, Alvarez-Sanchez MV, Napoleon B et al. Diagnostic endoscopic ultrasonography: assessment of safety and prevention of complications. World J Gastroenterol 2012; 18: 4659-4676
55 Adet A, Miquel R, Bombi JA et al. [Incidence and characteristics of pancreatic cystic neoplasms]. Gastroenterol Hepatol 2010; 33: 563-568
56 Faccioli N, Crippa S, Bassi C et al. Contrast-enhanced ultrasonography of the pancreas. Pancreatology 2009; 9: 560-566
57 Rickes S, Monkemuller K, Malfertheiner P. Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors. JOP 2006; 7: 584-592
58 Hocke M, Dietrich CF. Vascularisation pattern of chronic pancreatitis compared with pancreatic carcinoma: results from contrast-enhanced endoscopic ultrasound. Int J Inflam 2012; 2012: 420787
59 Dietrich CF, Braden B, Hocke M et al. Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J Cancer Res Clin Oncol 2008; 134: 635-643
60 Balthazar EJ. Pancreatitis associated with pancreatic carcinoma. Preoperative diagnosis: role of CT imaging in detection and evaluation. Pancreatology 2005; 5: 330-344
61 Wang J, Su T, Jia N et al. Computed tomographic and magnetic resonance imaging presentations of pancreatitis maldiagnosed as pancreatic carcinoma. Pancreas 2010; 39: 262-264
62 Hocke M, Schulze E, Gottschalk P et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006; 12: 246-250
63 Hocke M, Schmidt C, Zimmer B et al. [Contrast enhanced endosonography for improving differential diagnosis between chronic pancreatitis and pancreatic cancer]. Dtsch Med Wochenschr 2008; 133: 1888-1892
64 Hocke M, Ignee A, Topalidis T et al. Contrast-enhanced endosonographic Doppler spectrum analysis is helpful in discrimination between focal chronic pancreatitis and pancreatic cancer. Pancreas 2007; 35: 286-288
65 Saftoiu A, Vilmann P, Gorunescu F et al. Efficacy of an artificial neural network-based approach to endoscopic ultrasound elastography in diagnosis of focal pancreatic masses. Clin Gastroenterol Hepatol 2012; 10: 84-90
66 Saftoiu A, Vilmann P, Gorunescu F et al. Accuracy of endoscopic ultrasound elastography used for differential diagnosis of focal pancreatic masses: a multicenter study. Endoscopy 2011; 43: 596-603
67 Hirche TO, Ignee A, Barreiros AP et al. Indications and limitations of endoscopic ultrasound elastography for evaluation of focal pancreatic lesions. Endoscopy 2008; 40: 910-917
68 DʼOnofrio M, Gallotti A, Martone E et al. Solid appearance of pancreatic serous cystadenoma diagnosed as cystic at ultrasound acoustic radiation force impulse imaging. JOP 2009; 10: 543-546
69 Dietrich CF. Echtzeit-Gewebeelastographie. Anwendungsmöglichkeiten nicht nur im Gastrointestinaltrakt. Endoskopie Heute 2010; 23: 177-212
70 Dietrich CF. [3D real time contrast enhanced ultrasonography, a new technique]. Rofo 2002; 174: 160-163
71 Hocke M, Dietrich CF. New technology–combined use of 3D contrast enhanced endoscopic ultrasound techniques. Ultraschall Med 2011; 32: 317-318
72 Feingold S, Gessner R, Guracar IM et al. Quantitative volumetric perfusion mapping of the microvasculature using contrast ultrasound. Invest Radiol 2010; 45: 669-674
73 Geis NA, Katus HA, Bekeredjian R. Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. Curr Pharm Des 2012; 18: 2166-2183